000 | 01127 a2200349 4500 | ||
---|---|---|---|
005 | 20250516231142.0 | ||
264 | 0 | _c20150512 | |
008 | 201505s 0 0 eng d | ||
022 | _a1365-2230 | ||
024 | 7 |
_a10.1111/ced.12408 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aLynch, M | |
245 | 0 | 0 |
_aSitagliptin for severe psoriasis. _h[electronic resource] |
260 |
_bClinical and experimental dermatology _cOct 2014 |
||
300 |
_a841-2 p. _bdigital |
||
500 | _aPublication Type: Case Reports; Letter | ||
650 | 0 | 4 | _aAged |
650 | 0 | 4 |
_aArthritis, Psoriatic _xdrug therapy |
650 | 0 | 4 |
_aDipeptidyl-Peptidase IV Inhibitors _xtherapeutic use |
650 | 0 | 4 | _aFemale |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aPyrazines _xtherapeutic use |
650 | 0 | 4 | _aSitagliptin Phosphate |
650 | 0 | 4 | _aTreatment Outcome |
650 | 0 | 4 |
_aTriazoles _xtherapeutic use |
700 | 1 | _aTobin, A-M | |
700 | 1 | _aAhern, T | |
700 | 1 | _aO'Shea, D | |
700 | 1 | _aKirby, B | |
773 | 0 |
_tClinical and experimental dermatology _gvol. 39 _gno. 7 _gp. 841-2 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/ced.12408 _zAvailable from publisher's website |
999 |
_c24127754 _d24127754 |